| 10.37 -2.57 (-19.86%) | 09-15 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 14.93 |
1-year : | 16.99 |
| Resists | First : | 12.78 |
Second : | 14.55 |
| Pivot price | 13.16 |
|||
| Supports | First : | 9.93 |
Second : | 8.27 |
| MAs | MA(5) : | 12.34 |
MA(20) : | 13.15 |
| MA(100) : | 17.46 |
MA(250) : | 18.4 |
|
| MACD | MACD : | -1 |
Signal : | -0.9 |
| %K %D | K(14,3) : | 14.9  |
D(3) : | 13.5 |
| RSI | RSI(14): 22.2 |
|||
| 52-week | High : | 25.12 | Low : | 9.93 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ ALHC ] has closed below the lower bollinger band by 34.7%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ ALHC ] is to continue within current trading range. It is unclear right now based on current values. 41.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 12.31 - 12.38 | 12.38 - 12.44 |
| Low: | 9.76 - 9.84 | 9.84 - 9.91 |
| Close: | 10.25 - 10.37 | 10.37 - 10.47 |
Alignment Healthcare, Inc. is a technology-driven Medicare Advantage provider operating a healthcare platform focused squarely on the consumer. This organization delivers personalized medical services across the United States, primarily for elderly individuals and others requiring specific support, leveraging its suite of Medicare Advantage plans. The company directly owns and operates Medicare Advantage programs in California, North Carolina, and Nevada. Beyond its proprietary offerings, it also orchestrates and furnishes essential healthcare services—including professional, institutional, and supplementary care—for beneficiaries of select plans from unrelated Medicare Advantage Health Maintenance Organizations. Established in 2013, Alignment Healthcare maintains its corporate base in Orange, California.
Tue, 15 Sep 2026
Rosen Law Firm Encourages Alignment Healthcare, Inc. Investors to Inquire About Securities Class Action Investigation - ALHC - Business Wire
Tue, 15 Sep 2026
Alignment Healthcare stock falls post-Baird event (ALHC:NASDAQ) - Seeking Alpha
Mon, 14 Sep 2026
Precision Trading with Alignment Healthcare Inc. (ALHC) Risk Zones - Stock Traders Daily
Fri, 11 Sep 2026
Alignment Healthcare (ALHC) CEO stock sales tied to taxes and trading plan - Stock Titan
Thu, 10 Sep 2026
Alignment Healthcare (ALHC) trust plans $6.5M sale of pre-IPO shares - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Plans
|
|
| Shares Out | 207 (M) |
| Shares Float | 188 (M) |
| Held by Insiders | 2.7 (%) |
| Held by Institutions | 115.9 (%) |
| Shares Short | 23,530 (K) |
| Shares Short P.Month | 24,810 (K) |
| EPS | 0.18 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.27 |
| Profit Margin | 0.8 % |
| Operating Margin | 3.1 % |
| Return on Assets (ttm) | 3 % |
| Return on Equity (ttm) | 20 % |
| Qtrly Rev. Growth | 31.6 % |
| Gross Profit (p.s.) | 2.76 |
| Sales Per Share | 22.07 |
| EBITDA (p.s.) | 0.42 |
| Qtrly Earnings Growth | 142.8 % |
| Operating Cash Flow | 206 (M) |
| Levered Free Cash Flow | 189 (M) |
| PE Ratio | 54.57 |
| PEG Ratio | 0 |
| Price to Book value | 8.1 |
| Price to Sales | 0.46 |
| Price to Cash Flow | 10.46 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|